申请人:Arora Nidhi
公开号:US20120015962A1
公开(公告)日:2012-01-19
Compounds of the formula I or II:
wherein X, m, Ar, R
1
and R
2
are as defined herein. The subject compounds are useful for treatment of IRAK-mediated conditions.
式I或II的化合物:
其中X,m,Ar,R1和R2如本文所定义。所述化合物对于治疗IRAK介导的疾病是有用的。